Luke Beshar

Luke Beshar

Chairman

Luke Beshar has served on Protara’s board of directors since October 2018 and as its Chairman since October 2019. Luke previously served as the Executive Vice President and Chief Financial Officer of NPS Pharmaceuticals, Inc…

read more

MICHAEL SOLOMON, PhD

Director

Dr. Michael Solomon has served on Protara’s board of directors since May 2018. He serves as Chief Executive Officer of Ribometrix, Inc., a company focused on targeting RNA with small molecules…

read more
Michael Solomon, PhD
Barry Flannelly, PharmD, MBA

BARRY FLANNELLY, PharmD, MBA

Director

Dr. Barry Flannelly has served on Protara’s board of directors since July 2020 and is currently the Executive Vice President and General Manager, North America at Incyte… 

read more
Scott Braunstein, MD

Scott Braunstein, MD

Director

Dr. Scott Braunstein has served on Protara’s board of directors since June 2018. In August 2019, Dr. Braunstein began serving as President and Chief Executive Officer of Marinus Pharmaceuticals, Inc…

read more

Roger Garceau, MD

Director

Dr. Roger Garceau has served on Protara’s board of directors since January 2019 and has more than 30 years of broad pharmaceutical industry experience in drugs, biologics and combination drug/device products for…

read more
Roger Garceau, MD
Greg Sargen

Greg Sargen

Director

Greg Sargen has served on Protara’s board of directors since November 2019 and is a licensed CPA (inactive) with extensive experience working within the healthcare industry. Greg currently serves as Chief Financial Officer…

read more

Richard Levy, MD

Director

Dr. Richard Levy has served on Protara’s board of directors since December 2019 and has more than 25 years of experience in the pharmaceutical and biotechnology industries…

read more
Richard Levy, MD
Scroll to Top